Facebook Twitter LinkedIn Google Plus RSS

Teva acquires MicroDose in $40 million deal

By ,

Israel-based Teva Pharmaceutical Industries Ltd. announced today its acquisition of MicroDose Therapeutx, in the Monmouth Junction section of South Brunswick.

According to the announcement, Teva will acquire MicroDose's outstanding shares for $40 million, with $125 million in additional payments contingent on certain development and sales milestones. MicroDose specializes in inhalation products for lung diseases and infections.

Write to the Editorial Department at editorial@njbiz.com

Leave a Comment

test

Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy

Comments

close
Subscribe to Our Newsletters!
Click Here to Subscribe for Free Now!